Ciclesonide is a pro-drug inhaled corticosteroid activated by airway esterases to its pharmacologically active metabolite, offering lung-targeted anti-inflammatory activity for asthma and allergic rhinitis with minimal oral bioavailability and systemic side effects. Simson Pharma's Ciclesonide reference standard and impurities support stability-indicating method development for this inhaled glucocorticoid.
Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Ciclesonide Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.
